ArticleProceedings of the National Academy of Sciences of the United States of America2020

Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors.

Chen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.